Cardiovascular Diseases
Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice
Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study
Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia
.webp/jcr:content/low-risk-vte-thumb%20(3).webp)
.webp/jcr:content/jcr_content%20(9).webp)
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
.webp/jcr:content/jcr_content%20(7).webp)
.webp/jcr:content/jcr_content%20(5).webp)
.webp/jcr:content/Use-of-Lipid-Lowering-Therapies-Over-2-Years-thumb%20(1).webp)
Use of Lipid-Lowering Therapies Over 2 Years
Prescription patterns of lipidlowering therapies over time in patients with atherosclerotic cardiovascular disease
Findings from Gould study
.webp3/jcr:content/jcr_content%20(1).webp)
The European experience: Swedeheart and AIFA registries
Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.
.webp/jcr:content/jcr_content%20(16).webp)
.webp/jcr:content/jcr_content%20(21).webp)
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry
Events
Stay up to date and register for the latest events and view webinar recordings.
VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery
.jpg/jcr:content/image%20(41).jpg)
.jpg/jcr:content/image%20(40).jpg)
VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond
Prof. Joseph A. Caprini provides insights on VTE Risk in Hospital and beyond by supporting the initiative on preventing the number one preventable cause of death after surgery: fetal pulmonary embolism